Keyphrases
T Cells
100%
Cytotoxic T Lymphocytes
100%
Solid Tumors
100%
Mass Production
100%
Pluripotent Stem Cells
100%
Induced Pluripotent Stem Cells (iPSCs)
66%
Leukemia
33%
Allogeneic
33%
Xenograft Model
33%
Patient-derived Xenograft
33%
Therapeutic Efficacy
33%
Tumor Growth
33%
Adoptive Cell Therapy
33%
WT1 mutation
33%
Renal Cell Carcinoma
33%
T Lymphocyte Antigen
33%
HLA Haplotypes
33%
Medicine and Dentistry
Solid Malignant Neoplasm
100%
Cytotoxic T-Cell
100%
T Cell
100%
Pluripotent Stem Cell
100%
Xenograft
50%
Induced Pluripotent Stem Cell
50%
Tumor Progression
25%
Combination Therapy
25%
Leukemia
25%
Cell Therapy
25%
T Lymphocyte Antigen
25%
Haplotype
25%
Clear Cell Renal Cell Carcinoma
25%
T Cell Receptor
25%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
T Cell
100%
Cytotoxic T Cell
100%
Induced Pluripotent Stem Cell
50%
WT1
50%
Tumor Progression
25%
Haplotype
25%
T Cell Receptor
25%